Connection

Sakamuri Reddy to Osteitis Deformans

This is a "connection" page, showing publications Sakamuri Reddy has written about Osteitis Deformans.
Connection Strength

3.574
  1. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone. Bone. 2017 Aug; 101:236-244.
    View in: PubMed
    Score: 0.565
  2. SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone. J Cell Biochem. 2013 Sep; 114(9):2032-8.
    View in: PubMed
    Score: 0.437
  3. CXCL5 stimulation of RANK ligand expression in Paget's disease of bone. Lab Invest. 2013 Apr; 93(4):472-9.
    View in: PubMed
    Score: 0.422
  4. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology. 2011 Nov; 152(11):4180-9.
    View in: PubMed
    Score: 0.381
  5. FGF-2 stimulation of RANK ligand expression in Paget's disease of bone. Mol Endocrinol. 2009 Sep; 23(9):1445-54.
    View in: PubMed
    Score: 0.327
  6. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. J Cell Biochem. 2008 Jul 01; 104(4):1500-8.
    View in: PubMed
    Score: 0.306
  7. Elevated serum kininogen in patients with Paget's disease of bone: a role in marrow stromal/preosteoblast cell proliferation. J Cell Biochem. 2006 Aug 15; 98(6):1681-8.
    View in: PubMed
    Score: 0.268
  8. Etiologic factors in Paget's disease of bone. Cell Mol Life Sci. 2006 Feb; 63(4):391-8.
    View in: PubMed
    Score: 0.259
  9. Etiology of Paget's disease and osteoclast abnormalities. J Cell Biochem. 2004 Nov 01; 93(4):688-96.
    View in: PubMed
    Score: 0.237
  10. Experimental models of Paget's disease. J Bone Miner Res. 2006 Dec; 21 Suppl 2:P55-7.
    View in: PubMed
    Score: 0.068
  11. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J Bone Miner Res. 2006 Mar; 21(3):446-55.
    View in: PubMed
    Score: 0.064
  12. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease. Endocrinology. 2005 Apr; 146(4):2023-30.
    View in: PubMed
    Score: 0.060
  13. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):331-4.
    View in: PubMed
    Score: 0.057
  14. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease. J Bone Miner Res. 2004 Jul; 19(7):1154-64.
    View in: PubMed
    Score: 0.057
  15. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res. 2002 Jan; 17(1):145-51.
    View in: PubMed
    Score: 0.049
  16. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest. 2007 Jan; 117(1):133-42.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.